I mean exactly what I said, you’re endeavoring to make very small profits and succeeding. You’re just another trader who attempts to influence other holders to suit your position.
Your post regarding revenue demonstrates you have no idea how value is created in this sector. GW Pharma was valued at US$3 billion before they made one single cent from Epidiolex. They are the only company on my peer list with any revenue.
Ive been an IHL shareholder for more than 4 years and an MRZ shareholder since IPO which has the same management as CIA and prior to that I backed both of the Riversdale’s. Have a look at how that turned out. It’s all about people.
As an Australian I thank you for the tax revenue you are generating but you have no credibility on this thread and calling other shareholders “lemmings” is insulting.
IHL Price at posting:
24.0¢ Sentiment: Buy Disclosure: Held